US20240409582A1
University of North Texas Health Science Center
Embodiments of the invention are directed to inhibitors of MIEN1-mediated cancer signaling transduction pathways to inhibit cancer cell migration and their use as a cancer therapy. The inhibitors are a hexamer peptide and a heptamer peptide (therapeutic peptides) from the ITAM and the prenylation …